• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
M35

M35

Product ID M0035
Cas No. 142846-71-7
Purity ≥95%
Product Unit SizeCostQuantityStock
0.5 mg $110.30 Please Inquire
1 mg $220.50 Please Inquire
2.5 mg $419.00 Please Inquire
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

M35 is a peptide antagonist at galanin receptors that exhibits antidepressant and insulin-modulating activities. In the forced swim test, M35 decreases immobility time. M35 displays neuroprotective and cognition enhancing activities as well, improving acquisition time, decreasing the number of failed trials, and shortening escape latency in rodents undergoing the forced swim test, an animal model of spatial learning. M35 also suppresses pancreatitis-induced plasma hyperenzymemia and decreases myeloperoxidase activity, decreasing necrosis. Additionally, M35 decreases glucose uptake, PPARα expression, and membrane GLUT4 levels, attenuating insulin sensitivity in other animal models.

Product Info

Cas No.

142846-71-7

Purity

≥95%

Formula

C107H153N27O26

Formula Wt.

2233.58

Synonym

Galanin-(1-13)-bradykinin-(2-9)-amide

Solubility

Insoluble in water. Soluble in 60% acetonitrile with 0.1% TFA. Soluble in DMSO.

Shipping and Storage

Store Temp

-20°C

Ship Temp

Ambient

Downloads

MSDS

M0035 MSDS PDF

Info Sheet

M0035 Info Sheet PDF

References

Bu L, Liu Z, Zou J, et al. Blocking central galanin receptors attenuates insulin sensitivity in myocytes of diabetic trained rats. J Neurosci Res. 2013 Jul;91(7):971-7. PMID: 23653288.

Bhandari M, Kawamoto M, Thomas AC, et al. Galanin receptor antagonist m35 but not m40 or c7 ameliorates cerulein-induced acute pancreatitis in mice. Pancreatology. 2010;10(6):682-8. PMID: 21242707.

Jiang L, Shi M, Guo L, et al. Effect of M35, a neuropeptide galanin antagonist on glucose uptake translated by glucose transporter 4 in trained rat skeletal muscle. Neurosci Lett. 2009 Dec 25;467(2):178-81. PMID: 19835935.

Kuteeva E, Wardi T, Hökfelt T, et al. Galanin enhances and a galanin antagonist attenuates depression-like behaviour in the rat. Eur Neuropsychopharmacol. 2007 Jan;17(1):64-9. PMID: 16624535.

Ogren SO, Hökfelt T, Kask K, et al. Evidence for a role of the neuropeptide galanin in spatial learning. Neuroscience. 1992 Nov;51(1):1-5. PMID: 1281521.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • T9968

    Tyrphostin A25

    SK K+ channel blocker, EGFR inhibitor.

    ≥98%
  • G3453

    20(S)-Ginsenoside Rh2

    Triterpene saponin found in Panax.

    ≥98%
  • F8250

    Fumitremorgin C

    Mycotoxin found in Aspergillus and Penicillum; ...

    ≥98%
  • C9709

    Cycloheximide

    Protein synthesis inhibitor, used to measure pr...

    ≥98%
  • O9458

    Oxolinic Acid

    Fluoroquinolone; bacterial DNA gyrase inhibitor...

    ≥98%
  • B1746

    Belinostat

    HDAC inhibitor.

    ≥98%
  • C179602

    CEP-28122

    ALK inhibitor.

    ≥98%
  • T2402

    TG100-115

    p110δ and p110γ PI3K inhibitor.

    ≥98%
  • M174446

    Meleagrin

    FabI inhibitor

    ≥99%
  • L1761

    Leptomycin B

    Polyketide; CRM1 inhibitor.

    ≥98%
  • T0394

    (+)-Taxifolin

    Catechol-type flavonoid; fatty acid synthesis i...

    ≥98%
  • C0016

    Caerulomycin A

    Bipyridamine toxin.

    ≥96%
  • B4402

    Blasticidin S Hydrochloride

    Protein translation inhibitor.

    ≥98%
  • A2400

    AG-1024

    Tyrphostin; IGF-1R inhibitor.

    ≥98%
  • D0004

    Dabrafenib

    B-Raf and c-Raf inhibitor.

    ≥98%
  • C211324

    CFI-400945

    PLK4 inhibitor.

    ≥98%
  • C1876

    Cetirizine Dihydrochloride

    Histamine H1 antagonist.

    ≥99%
  • O4917

    Omeprazole

    H+/K+ ATPase inhibitor.

    ≥98%
  • C0169

    Carbenoxolone Disodium

    Synthetic derivative of glycyrrhizin; connexin ...

    ≥97%
  • C291342

    CHIR-99021

    GSK3 inhibitor.

    ≥98%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2025 LKT Laboratories, All Rights Reserved - Products for research use only